115 related articles for article (PubMed ID: 1769127)
1. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
Schlemmer A; Johansen JS; Pedersen SA; Jørgensen JO; Hassager C; Christiansen C
Clin Endocrinol (Oxf); 1991 Dec; 35(6):471-6. PubMed ID: 1769127
[TBL] [Abstract][Full Text] [Related]
2. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
Rodríguez-Arnao J; James I; Jabbar A; Trainer PJ; Perrett D; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412
[TBL] [Abstract][Full Text] [Related]
3. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
[TBL] [Abstract][Full Text] [Related]
4. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
5. Urinary pyridinoline and deoxypyridinoline excretion in children.
Shaw NJ; Dutton J; Fraser WD; Smith CS
Clin Endocrinol (Oxf); 1995 Jun; 42(6):607-12. PubMed ID: 7634501
[TBL] [Abstract][Full Text] [Related]
6. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males.
Vandeweghe M; Taelman P; Kaufman JM
Clin Endocrinol (Oxf); 1993 Oct; 39(4):409-15. PubMed ID: 8287567
[TBL] [Abstract][Full Text] [Related]
7. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
8. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
[TBL] [Abstract][Full Text] [Related]
9. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
[TBL] [Abstract][Full Text] [Related]
10. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
[TBL] [Abstract][Full Text] [Related]
11. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency.
Fujimoto S; Kubo T; Tanaka H; Miura M; Seino Y
J Clin Endocrinol Metab; 1995 Jun; 80(6):1922-8. PubMed ID: 7775642
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
[TBL] [Abstract][Full Text] [Related]
13. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
[TBL] [Abstract][Full Text] [Related]
14. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
16. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links.
Pardini DP; Sabino AT; Meneses AM; Kasamatsu T; Vieira JG
Sao Paulo Med J; 2000 Jan; 118(1):3-6. PubMed ID: 10685120
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.
Johansen JS; Pedersen SA; Jørgensen JO; Riis BJ; Christiansen C; Christiansen JS; Skakkebaek NE
J Clin Endocrinol Metab; 1990 Apr; 70(4):916-9. PubMed ID: 2180981
[TBL] [Abstract][Full Text] [Related]
18. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
19. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
20. Rapid decrease of urinary pyridinoline excretion in growth hormone deficient children following discontinuation of growth hormone therapy.
Kuno T; Tasaki H; Miyazaki S; Horie H
Acta Paediatr Jpn; 1997 Feb; 39(1):18-20. PubMed ID: 9124047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
